首頁 > 市場調查報告書 > 醫療設備

呼吸器

市場調查報告書

商品編碼

1672813

呼吸吸入器市場按類型、產品、應用、最終用戶和地區分類

Respiratory Inhalers Market, By Type, By Product, By Application, By End User, By Geography

出版日期: 2025年02月12日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球呼吸吸入器市場規模估計為 351 億美元，預計到 2032 年將達到 528.1 億美元，2025 年至 2032 年的年複合成長率(CAGR)為 6.0%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	351億美元
效能資料	2020-2024	預測期	2025-2032
預測期：2025 年至 2032 年複合年成長率	6.00％	2032 年金額預測	528.1億美元

數字。 2025 年呼吸吸入器市場佔有率（按地區分類）

呼吸吸入器是一種用於給藥治療氣喘和慢性阻塞性肺病等呼吸系統疾病的醫療設備。這些有助於透過吸入將所需量的藥量直接輸送到呼吸道。由於環境因素導致的呼吸系統疾病盛行率上升、易患此類疾病的老年人口不斷增加以及人們對吸入器治療的認知不斷提高，可能會推動市場成長。吸入器藥物輸送技術的進步、智慧和數位吸入器的發展以及功效更高的組合吸入器的推出也將推動市場成長。然而，高昂的治療費用以及農村地區缺乏治療機會可能會阻礙其廣泛採用。

市場動態

全球呼吸吸入器市場的成長主要受到全球呼吸系統疾病盛行率不斷上升的推動。近幾十年來，由於污染水平上升、生活方式改變和人口老化，氣喘和慢性阻塞性肺病的發生率急劇上升。根據世界衛生組織的資料，目前約有3億人患有氣喘，超過2億人患有慢性阻塞性肺病。早期診斷和有效吸入療法改善了這些疾病的治療前景。低收入國家認知度較低以及一些國家品牌藥品價格高可能會阻礙市場成長。然而，透過研究和開發新型呼吸藥物、將數位技術融入設備以及開發結合不同類型吸入器特性的混合吸入器，可以克服這些挑戰，使患者能夠負擔得起、更方便地獲得有效治療。

研究的主要特點

本報告對全球呼吸吸入器市場進行了詳細分析，並提供了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設基準年為 2024 年。

它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，介紹了全球呼吸吸入器市場的主要企業概況。

研究涉及的主要企業包括葛蘭素史克、默克、勃林格殷格翰、阿斯特捷利康、3M、Teva Pharmaceutical 和 Sunovion Pharmaceuticals。

本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

全球呼吸吸入器市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。

相關人員可以透過全球呼吸吸入器市場分析中使用的各種策略矩陣來促進他們的決策。

公司簡介
- Koninklijke Philips NV
- General Electric Healthcare
- ResMed Inc.
- Fisher &Paykel Healthcare
- Medtronic
- Boehringer Ingelheim
- GlaxoSmithKline plc
- AstraZeneca
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Mylan NV
- Roche Holding AG
- Johnson & Johnson
- Sanofi SA
- Merck & Co., Inc.
- Hoffmann-La Roche Ltd
- Otsuka Pharmaceutical Co., Ltd.
- Cipla Limited

第 11 章分析師建議

興衰
一致的機會地圖

第 12 章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI227

Global Respiratory Inhalers Market is estimated to be valued at USD 35.10 Bn in 2025 and is expected to reach USD 52.81 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.0% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 35.10 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.00%	2032 Value Projection:	USD 52.81 Bn

Figure. Respiratory Inhalers Market Share (%), By Region 2025

Respiratory inhalers are medical devices used for administration of drugs to treat respiratory diseases like asthma and COPD. These help to deliver the required dosage of medication directly to the airways through inhalation. Rising prevalence of respiratory diseases due to environmental factors, growing geriatric population susceptible to such conditions, and increasing awareness about inhaler therapies can drive the market growth. Advancements in inhaler drug delivery technologies, development of smart and digital inhalers, and introduction of combo inhalers with improved efficacy can also drive the market growth. However, high treatment costs and lack of availability in rural regions may hamper its widespread adoption.

Market Dynamics:

Global respiratory inhalers market growth is primarily driven by growing prevalence of respiratory diseases worldwide. Asthma and COPD incidence has increased dramatically in recent decades due to rising pollution levels, changing lifestyle trends, and aging population. As per data from WHO, around 300 million people currently suffer from asthma while over 200 million have COPD. Early diagnosis and availability of effective inhaler therapies have improved the treatment outlook of these conditions. Lack of awareness in low-income nations and high costs of branded drugs in some countries can hamper the market growth. However, ongoing R&D into newer categories of respiratory medicines, integration of digital technology into devices, and development of hybrid inhalers combining attributes of different types of inhalers can overcome these challenges by making effective treatment more affordable and accessible to patients.

Key Features of the Study:

This report provides in-depth analysis of the global respiratory inhalers market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global respiratory inhalers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include GlaxoSmithKline, Merck, Boehringer Ingelheim, AstraZeneca, 3M, Teva Pharmaceutical, and Sunovion Pharmaceuticals

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global respiratory inhalers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global respiratory inhalers market

Detailed Segmentation-

By Type
- Manually Operated
- Digitally Operated
By Product
- Dry Powder Inhaler
- Metered Dose Inhaler
- Others
By Application
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Arterial Hypertension
- Other
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Koninklijke Philips N.V.
- General Electric Healthcare
- ResMed Inc.
- Fisher & Paykel Healthcare
- Medtronic
- Boehringer Ingelheim
- GlaxoSmithKline plc
- AstraZeneca
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Roche Holding AG
- Johnson & Johnson
- Sanofi S.A.
- Merck & Co., Inc.
- Hoffmann-La Roche Ltd
- Otsuka Pharmaceutical Co., Ltd.
- Cipla Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Respiratory Inhalers Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Respiratory Inhalers Market, By Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Manually Operated
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Digitally Operated
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Respiratory Inhalers Market, By Product, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Dry Powder Inhaler
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Metered Dose Inhaler
- Mammography
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Respiratory Inhalers Market, By Application, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Asthma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chronic Obstructive Pulmonary Disease (COPD)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Arterial Hypertension
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Respiratory Inhalers Market, By End User, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Hospitals & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Respiratory Care Center
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Academic and Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Respiratory Inhalers Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Company Profiles
- Koninklijke Philips N.V.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- General Electric Healthcare
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- ResMed Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Fisher & Paykel Healthcare
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Medtronic
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boehringer Ingelheim
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GlaxoSmithKline plc
- AstraZeneca
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Roche Holding AG
- Johnson & Johnson
- Sanofi S.A.
- Merck & Co., Inc.
- Hoffmann-La Roche Ltd
- Otsuka Pharmaceutical Co., Ltd.
- Cipla Limited